| Literature DB >> 26288583 |
Markus Albertsmeier1, Sebastian Pratschke1, Irshad Chaudry2, Martin K Angele1.
Abstract
BACKGROUND: Studies in human as well as animal models indicate a gender-specific responsiveness of the immune and organ systems with regard to shock, trauma, and sepsis.Entities:
Keywords: Gender; Hemorrhagic shock; Immune depression; Immune modulation; Sex steroids
Year: 2014 PMID: 26288583 PMCID: PMC4513799 DOI: 10.1159/000360149
Source DB: PubMed Journal: Viszeralmedizin ISSN: 1662-6664
Fig. 1Schematic illustration of the effect of gender on cell-mediated immune responses following trauma and severe blood loss.
Multi-institutional studies on the out-come of trauma patients depending on gender
| Study, year [ref.] | Age group, years | ISS | n | Mortality rate male vs. female | p |
|---|---|---|---|---|---|
| Morris et. al., 1990 [ | all | all | 199,737 | – | n.s. |
| ≥40 | ≤25 | – | RR | <0.05 | |
| Wohltmann et al., 2001 [ | all | all | 20,261 | 8 vs. 7% | n.s. |
| <50 | all | 15,839 | 7 vs. 5% | <0.002 | |
| <50 | ≥25 | 2,138 | 33 vs. 25% | <0.026 | |
| Gannon et al., 2002 [ | 18–65 | all | 22,332 | 7 vs. 5% | n.s. |
| George et al., 2003 [ | ≥20 | all | 155,691 | 6.3 vs. 4.5% | <0.001 |
n.s. = Not significant.
Relative risk of mortality for males.
Experimental results on the effect of sex steroids and gender following trauma, shock, and sepsis
| Effect of trauma, shock, and sepsis | ||
|---|---|---|
| males | females (proestrus) | |
| Immune response – gender | splenic/peritoneal Mφ cytokine release ↓ Mφ antigen presentation ↓ T cell proliferation and Th1 release ↓ T cell Th2 (IL-10) ↑ | splenic/peritoneal Mφ cytokine release → Mφ antigen presentation → T cell proliferation and Th1 release → T cell Th2 (IL-10) → |
| Immune response – sex steroids | immunosuppressive | immunoprotective |
| Mortality after sepsis | 70% (in mice after CLP) | 20% (in mice after CLP) |
| Effect of sex hormone depletion | castration: immunoprotective | ovariectomy: immunosuppressive |
| Treatment option | flutamide (testosterone receptor antagonist) | estrogen (in non-proestrus females) |
| estrogen | DHEA | |
| DHEA (via estrogen receptor) | ||
CLP = Cecal ligation and puncture.